VCIM
NVNO

Velan Capital Investment Management’s enVVeno Medical NVNO Stock Holding History

Velan Capital Investment Management’s Portfolio NVNO Stock Details NVNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-4,921
Closed -$937K – 24
2024
Q1 		$937K Hold
4,921
– – 0.43% 19
2023
Q4 		$885K Buy
+4,921
New +$784K 0.52% 18
2022
Q1 		– Sell
-2,128
Closed -$491K – 27
2021
Q4 		$491K Buy
+2,128
New +$599K 0.38% 24

Other funds holding NVNO

KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return

Velan Capital Investment Management's NVNO Position: Q2 2024 in Review

Velan Capital Investment Management sold out of enVVeno Medical (NVNO) in Q2 2024, closing a stake of 4,921 shares — an estimated $937K sold.

Velan Capital Investment Management first reported a position in NVNO in Q4 2021 and held it in 3 quarters. The position peaked at $937K in Q1 2024. 26 funds tracked by Wall St. Rank hold NVNO as of Q2 2024.

  • Velan Capital Investment Management reported no remaining enVVeno Medical position as of Q2 2024 after selling out during the quarter.
  • Velan Capital Investment Management sold 4,921 enVVeno Medical shares in Q2 2024, an estimated $937K.
  • Velan Capital Investment Management first reported a position in enVVeno Medical in Q4 2021 and held it in 3 quarters.
  • Velan Capital Investment Management's enVVeno Medical position peaked at $937K in Q1 2024.
  • 26 funds tracked by Wall St. Rank held enVVeno Medical as of Q2 2024.

Based on Velan Capital Investment Management's 13F filing for Q2 2024, filed 14 Aug 2024.